Description
EMPA-Q 10mg tablets offer comprehensive support for adults managing type 2 diabetes, heart failure, and chronic kidney disease. Each tablet contains 10mg of Empagliflozin, an advanced SGLT2 inhibitor. This medication works by helping your kidneys excrete excess glucose from your body through urine, thereby effectively lowering blood sugar levels. Beyond its primary role in glycemic control, EMPA-Q 10mg is also clinically proven to significantly reduce the risk of cardiovascular death, hospitalization for heart failure, and the progression of chronic kidney disease in eligible adult patients. Taken once daily, with or without food, it forms a crucial part of a holistic management plan, complementing a healthy diet and regular exercise for enhanced overall health and well-being.
